ShareValue scores for 688068.SHG: Valuation 40, Quality 30, Growth 48, Health 45.

688068.SHG
SSE

Beijing Hotgen Biotech Co Ltd

CN¥112.14(+7.63%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 16%
Valuation
40
Fair Value
Price vs Value
Quality
30
Weak
Business Strength
Growth
48
Moderate
Revenue & Earnings
Health
45
Moderate
Financial Stability
Momentum
65
Bullish
Price Trend

Company Details

About

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers public safety solutions such as drug tasting, customs disease control, bioterrorism and food safety solutions. The company also provides clinical diagnostics and product solutions, including upconversion light, chemiluminescence, sugar capture, microfluidics, and genetic testing for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. Beijing Hotgen Biotech Co., Ltd. was founded in 2005 and is based in Beijing, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026